Circulating tumor cells in metastatic breast cancer

The aim of the current study was to assess the prognostic value of baseline circulating tumor cells (CTCs) in a large cohort of patients with newly diagnosed metastatic breast cancer (MBC).

[1]  Black Mm,et al.  Nuclear structure in cancer tissues. , 1957 .

[2]  The world Health Organization Histological Typing of Breast Tumors--Second Edition. The World Organization. , 1982, American journal of clinical pathology.

[3]  William H. Hartmann,et al.  The World Health Organization Histological Typing of Breast Tumors—Second Edition , 1982 .

[4]  Terry L. Smith,et al.  Is breast cancer survival improving? , 2004, Cancer.

[5]  M. Black,et al.  Nuclear structure in cancer tissues. , 1957, Surgery, gynecology & obstetrics.

[6]  G. Hortobagyi,et al.  Multivariate analysis of prognostic factors in metastatic breast cancer. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  G. T. Budd,et al.  Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival , 2006, Clinical Cancer Research.

[8]  Kristine R Broglio,et al.  Circulating tumor cells in metastatic breast cancer: biologic staging beyond tumor burden. , 2007, Clinical breast cancer.

[9]  M. Piccart,et al.  Second and subsequent lines of chemotherapy for metastatic breast cancer: what did we learn in the last two decades? , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  Jonathan W. Uhr,et al.  Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases , 2004, Clinical Cancer Research.

[11]  R. Bast,et al.  American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  A. Jemal,et al.  Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.

[13]  C. Rao,et al.  Peripheral blood tumor cell load reflects the clinical activity of the disease in patients with carcinoma of the breast. , 2000, International journal of oncology.

[14]  S. Edge,et al.  Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual. , 2003, The Surgical clinics of North America.

[15]  A. Gown,et al.  Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma , 2004, Clinical Cancer Research.

[16]  C. D. HAAGENSEN,et al.  Diseases of the Breast , 1972 .

[17]  R. Tibshirani,et al.  Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[18]  D. Morton,et al.  Treatment of metastatic disease. , 1979, Advances in surgery.

[19]  Leon W.M.M. Terstappen,et al.  Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer , 2006, Clinical Cancer Research.

[20]  M. Piccart,et al.  Facts and controversies in systemic treatment of metastatic breast cancer. , 2004, The oncologist.

[21]  Alison Stopeck,et al.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.

[22]  R. Carlson,et al.  Goals and objectives in the management of metastatic breast cancer. , 2003, The oncologist.

[23]  G. Hortobagyi,et al.  Prognostic factors in metastatic breast cancer treated with combination chemotherapy. , 1979, Cancer research.